Document is current
Any future updates will be listed below
-
Authors
Hamidi, Fardin
Muhler, Fabian
Skopp, Gisela
Rusnak, Jonas
Speer, Claudius
Michels, Guido
Frey, Norbert
Zelniker, Thomas A.
Preusch, Michael R.
-
Funding
Funding for this research was provided by:
Klaus Tschira Stiftung
Universitätsklinikum Heidelberg
- License Information
-
More Information
Article History
Received: 27 January 2026
Accepted: 6 June 2026
First Online: 22 June 2026
Declarations
:
: FH has no conflicts of interest. FM has no conflicts of interest. GS has no conflicts of interest. JR has no conflicts of interest. CS has no conflicts of interest. GM has no conflicts of interest. NF has no conflicts of interest. TAZ reports research grants from the Austrian Science Funds, and Boehringer Ingelheim; honoraria for serving on advisory boards from Boehringer Ingelheim and Bayer AG; personal fees from Alkem Lab. Ltd, AstraZeneca, Bayer AG, Boehringer Ingelheim, and Sun Pharmaceutical Industries, and educational grants from Eli Lilly and Company. MPR has no conflicts of interest.
: The authors declare the following financial interests/personal relationships which may be considered as potential competing interests: TAZ reports research grants from the Austrian Science Funds, and Boehringer Ingelheim; honoraria for serving on advisory boards from Boehringer Ingelheim and Bayer AG; personal fees from Alkem Lab. Ltd, AstraZeneca, Bayer AG, Boehringer Ingelheim and Sun Pharmaceutical Industries and educational grants from Eli Lilly and Company. All other authors declare that they have no known competing financial interests or personal relationships that could have influenced the work reported in this paper.
